Whalesbook
GAIL (India) Limited is significantly expanding its presence in India's compressed biogas (CBG) sector through a substantial investment in Leafiniti Bioenergy Private Limited. The company is acquiring a 49% stake for ₹130 million, aiming to establish CBG facilities across various Indian states. This move into green energy is designed to boost production of CBG and organic manure, create jobs, and reduce reliance on fossil fuels.
This strategic push into bioenergy comes as GAIL's core natural gas operations face pressure on profit margins. For the nine months ending December 31, 2025, net profit fell year-on-year, even as revenue from operations saw a modest increase. This financial performance, coupled with GAIL's stock decline of over 20% in the past year and a lower valuation compared to industry peers, highlights the company's efforts to diversify and find new growth avenues.
Project Details and Policy Support
The venture with Leafiniti Bioenergy, a subsidiary of TruAlt Bioenergy Limited, plans to build six new CBG plants. These facilities are projected to produce 72 tonnes of CBG daily, amounting to nearly 24,000 tonnes annually, along with significant quantities of organic manure.
The government's Compressed Biogas Obligation (CBO) requires gas companies to blend CBG into their natural gas supply, with targets increasing over the next few years. Initiatives like the SATAT (Sustainable Alternative Towards Affordable Transportation) scheme actively encourage CBG production to reduce India's substantial fuel import dependence. GAIL is also involved in a scheme to blend CBG into city gas distribution networks.
Broader Industry Moves and GAIL's Capital Spending
GAIL's focus on green energy mirrors a trend among other major state-owned energy companies like ONGC and NTPC, which have established dedicated green energy divisions. However, capital spending strategies differ across the sector. Bharat Petroleum Corporation Limited (BPCL) is increasing its capital expenditure, particularly in petrochemicals, while Indian Oil Corporation (IOC) and ONGC are reducing their investment budgets.
GAIL's own capital expenditure includes ₹2,256 crore for petrochemical projects and the ₹130 million allocated for this bioenergy investment. This diversification strategy proceeds alongside the continued expansion of GAIL's extensive natural gas pipeline network, which now exceeds 18,000 kilometers.
Financial Challenges and Risks
GAIL's recent financial results have raised questions about the sustainability of its core operations' profitability. The year-on-year drop in net profit, even when accounting for exceptional income in the prior period, points to challenges in maintaining margins. The company's stock has also been volatile, trading near its 52-week low, reflecting investor concerns.
Financial analyses suggest that GAIL's stock may be trading below its intrinsic value based on future cash flows, indicating potential overvaluation relative to its long-term earning potential. Furthermore, a relatively low return on equity over the past three years suggests inefficiencies in generating value from its assets. Balancing the substantial capital required for new ventures like bioenergy against the performance of its primary gas transmission and sales businesses remains crucial for GAIL's financial health.
Strategic Outlook
The mandated CBG blending requirements in India create a strong, long-term demand for biogas producers, offering a more predictable market. GAIL's investment is strategically timed to benefit from this policy-driven growth. The company's vast pipeline infrastructure could also provide logistical advantages for distributing CBG. Continued infrastructure development and diversification into renewable energy segments like bioenergy are key components of GAIL's strategy to navigate the changing energy market and maintain its role in India's energy security.